Home › Brain Tumors › Alabama
Brain Tumors clinical trials in Alabama
5 studies for Brain Tumors are looking for participants at sites in Alabama.
Cities in Alabama
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07326566A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
- University of Alabama, Birmingham
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT07428616A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- University of Alabama at Birmingham Cancer Center, Birmingham
- Thomas Hospital, Fairhope
- Mobile Infirmary Medical Center, Mobile
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT04511013HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- University of Alabama at Birmingham Cancer Center, Birmingham
RecruitingPhase 1
36 Months – 22 Years · All sexes · Updated Sep 4, 2026 · NCT03911388Trial of Differential Margins in Single Isocenter Radiosurgery of Brain Metastases
- University of Alabama at Birmingham (UAB) Hazelrig-Salter Radiation Oncology Center, Birmingham
Recruiting
Ages 19 and older · All sexes · Updated Jul 30, 2026 · NCT06857006From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.